文献速递腹部技术与安全CT

腹部CT偶然发现的脾脏肿块是否需要进一步检查:一项观察性研究

The Incidental Splenic Mass at CT: Does It Need Further Work-up? An Observational Study.
PubMed 文献 · Radiology · 2018-01-24

该回顾性研究纳入2002至2008年间腹部和胸部CT发现脾脏肿块的379例患者,分为恶性肿瘤病史组、症状相关组和偶然发现组,比较各组恶性脾脏肿块的发生率。偶然发现组恶性率仅1.0%,显著低于恶性肿瘤病史组的33.8%和症状相关组的27.6%(P < .0001),作者认为偶然发现的脾脏肿块可能不需要随访。

要点

  • 偶然发现组恶性脾脏肿块发生率仅1.0%,远低于恶性肿瘤病史组33.8%和症状相关组27.6%(P < .0001)。
  • 偶然发现组2例恶性肿块均为其他器官同时性肿瘤已明确诊断,并非影像上性质不确定。
  • 作者认为偶然发现的脾脏肿块可能不需要随访。

核心结论

  • 偶然发现的脾脏肿块恶性可能性很低(1.0%),因此可能不需要对偶然发现的脾脏肿块进行随访。

研究设计与样本

  • 经机构审查委员会批准、符合HIPAA的回顾性研究,检索2002至2008年腹部和胸部CT数据库中脾脏肿块患者,最终纳入379例,分为恶性肿瘤病史组145例(38.3%)、症状相关组29例(7.6%)和偶然发现组205例(54.1%)。

关键影像表现/征象

  • 偶然发现组2例恶性肿块分别为新诊断淋巴瘤1例(50%)和卵巢癌转移1例(50%)。
  • 偶然发现组的恶性脾脏肿块并非性质不确定,因为其他器官的同时性肿瘤已可诊断恶性。

诊断标准与关键数值

  • 恶性脾脏肿块发生率:恶性肿瘤病史组49/145(33.8%),症状相关组8/29(27.6%),偶然发现组2/205(1.0%),P < .0001。
  • 最终诊断确认方式:影像随访83.9%,临床随访13.7%,病理检查2.4%。

临床应用与阅片要点

  • 在阅片和报告中遇到偶然发现的脾脏肿块时,可提示恶性可能性很低(1.0%),但需结合患者有无恶性肿瘤病史或相关症状综合判断。
  • 偶然发现组恶性病例均伴有其他器官同时性肿瘤,阅片时应注意寻找脾外原发灶以辅助定性。
  • 作者认为偶然发现的脾脏肿块可能不需要随访。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate whether an incidentally noted splenic mass at abdominal computed tomography (CT) requires further imaging work-up. Materials and Methods In this institutional review board-approved HIPAA-compliant retrospective study, a search of a CT database was performed for patients with splenic masses at CT examinations of the abdomen and chest from 2002 to 2008. Patients were divided into three groups: group 1, patients with a history of malignancy; group 2, patients with symptoms such as weight loss, fever, or pain related to the left upper quadrant and epigastrium; and group 3, patients with incidental findings. Patients' CT scans, follow-up examinations, and electronic medical records were reviewed. Final diagnoses of the causes of the masses were confirmed with imaging follow-up (83.9%), clinical follow-up (13.7%), and pathologic examination (2.4%). Results This study included 379 patients, 214 (56.5%) women and 165 (43.5%) men, with a mean age ± standard deviation of 59.3 years ± 15.3 (range, 21-97 years). There were 145 (38.3%) patients in the malignancy group, 29 (7.6%) patients in the symptomatic group, and 205 (54.1%) patients in the incidental group. The incidence of malignant splenic masses was 49 of 145 (33.8%) in the malignancy group, eight of 29 (27.6%) in the symptomatic group, and two of 205 (1.0%) in the incidental group (P < .0001). The incidental group consisted of new diagnoses of lymphoma in one (50%) patient and metastases from ovarian carcinoma in one (50%) patient. Malignant splenic masses in the incidental group were not indeterminate, because synchronous tumors in other organs were diagnostic of malignancy. Conclusion In an incidental splenic mass, the likelihood of malignancy is very low (1.0%). Therefore, follow-up of incidental splenic masses may not be indicated. © RSNA, 2018.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Siewert B, Millo NZ, Sahi K, et al. The Incidental Splenic Mass at CT: Does It Need Further Work-up? An Observational Study. Radiology. 2018. PMID: 29369753. doi:10.1148/radiol.2017170293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。